César Magro-Checa
César Magro-Checa
Rheumatologist, Leiden University Medical Center
Verified email at lumc.nl
TitleCited byYear
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility
FD Carmona, SL Mackie, JE Martín, JC Taylor, A Vaglio, S Eyre, ...
The American Journal of Human Genetics 96 (4), 565-580, 2015
Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives
C Magro-Checa, EJ Zirkzee, TW Huizinga, GM Steup-Beekman
Drugs 76 (4), 459-483, 2016
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
A Serrano, A Marquez, SL Mackie, FD Carmona, R Solans, ...
Annals of the rheumatic diseases 72 (11), 1882-1886, 2013
A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus
E Ercan, C Ingo, O Tritanon, C Magro-Checa, A Smith, S Smith, ...
NeuroImage: Clinical 8, 337-344, 2015
Demyelinating disease in SLE: is it multiple sclerosis or lupus?
CM Checa, D Cohen, ELEM Bollen, MA van Buchem, TWJ Huizinga, ...
Best Practice & Research Clinical Rheumatology 27 (3), 405-424, 2013
Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis
C Magro-Checa, ANP Casado, E Borrego-García, E Raya-Álvarez, ...
Amyloid 18 (4), 235-239, 2011
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of …
E López‐Isac, JE Martín, S Assassi, CP Simeón, P Carreira, ...
Arthritis & rheumatology 68 (9), 2338-2344, 2016
Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites
E Ercan, C Magro-Checa, R Valabregue, F Branzoli, ET Wood, ...
Brain 139 (5), 1447-1457, 2016
Confirmation of− 174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome
CL Dávila-Fajardo, A Márquez, D Pascual-Salcedo, MJM Ramos, ...
Pharmacogenetics and genomics 24 (1), 1-5, 2014
Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet’s disease
MC Cénit, N Ortego-Centeno, E Raya, JL Callejas, FJ García-Hernandez, ...
Human immunology 74 (2), 230-233, 2013
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
A Ferreiro-Iglesias, A Montes, E Perez-Pampin, JD Canete, E Raya, ...
The pharmacogenomics journal 16 (2), 137, 2016
Lack of validation of genetic variants associated with anti–tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta …
A Márquez, A Ferreiro-Iglesias, CL Dávila-Fajardo, A Montes, ...
Arthritis research & therapy 16 (2), R66, 2014
Association of 25-hydroxyvitamin D with metabolic syndrome in patients with psoriasis: a case-control study
J Orgaz-Molina, C Magro-Checa, MA Arrabal-Polo, E Raya-Álvarez, ...
Acta dermato-venereologica 94 (2), 142-146, 2014
Calcium pyrophosphate crystal deposition disease: diagnosis and treatment
JL Rosales-Alexander, JB Aznar, C Magro-Checa
Open access rheumatology: research and reviews 6, 39, 2014
Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort
C Magro-Checa, EJ Zirkzee, LJJ Beaart-van de Voorde, HA Middelkoop, ...
Rheumatology 56 (10), 1676-1683, 2017
Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study
JL Rosales-Alexander, J Balsalobre Aznar, S Pérez-Vicente, ...
Rheumatology 54 (8), 1459-1463, 2015
C1q deficiency and neuropsychiatric systemic lupus erythematosus
RA van Schaarenburg, C Magro-Checa, JA Bakker, YK Teng, IM Bajema, ...
Frontiers in immunology 7, 647, 2016
PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6
NY Oparina, AM Delgado-Vega, M Martinez-Bueno, C Magro-Checa, ...
Annals of the rheumatic diseases 74 (3), e14-e14, 2015
Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index
JL Rosales-Alexander, J Salvatierra, J Llorca, C Magro-Checa, ...
Clin Exp Rheumatol 32, 237-42, 2014
Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts
M Ziegelasch, MAM van Delft, P Wallin, T Skogh, C Magro-Checa, ...
Arthritis research & therapy 18 (1), 289, 2016
The system can't perform the operation now. Try again later.
Articles 1–20